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Replication of the hepadnavirus DNA genome is accomplished via reverse transcription of an intermediate,
pregenomic RNA molecule. This process is likely to be carried out by a virally encoded, multifunctional
polymerase which possesses DNA- and RNA-dependent DNA polymerase and RNase H activities. However, the
nature of the product(s) of the polymerase gene predicted to mediate these functions is unclear. Biochemical
studies of the polymerase protein(s) have been limited by its apparent low abundance in virus particles and,
until recently, the inability to express active polymerase protein(s) heterologously. We have used activity gel
assays to detect DNA- and RNA-dependent DNA polymerase activities associated with highly purified duck
hepatitis B virus (DHBV) core particles (S. M. Oberhaus and J. E. Newbold, J. Virol. 67:6558–6566, 1993). Now
we report that the same approach identifies a 35-kDa RNase H activity in association with highly purified
DHBV core particles and crude preparations of virions from DHBV-infected ducks and woodchuck hepatitis
virus-infected woodchucks. This is the first report of the detection of an hepadnavirus-associated RNase H
activity. Its apparent size is smaller than any of the DNA polymerase activities that we detected previously and
significantly smaller than the full-length protein predicted from the polymerase open reading frame (p85 for
DHBV). These data suggest that the viral polymerase and RNase H activities are separable and that these
enzymes may coordinate their activities in vivo by forming a complex.
Hepadnaviruses are characterized by their small (;3,000
bp), partially double-stranded DNA genomes and a replication
scheme which involves reverse transcription of an intermediate
RNA molecule (for reviews, see references 44 and 51). Mem-
bers of the Hepadnaviridae family have been divided into two
groups, those which infect mammalian species (e.g., human
hepatitis B virus and woodchuck hepatitis virus [WHV]) and
those which infect avian species (e.g., duck hepatitis B virus
[DHBV]).
Several steps in the replication of the viral genome have
been shown to take place within cytoplasmic core particles
which encapsidate the pregenomic RNA molecule and a DNA
polymerase (DNAp) activity (56). This process of reverse tran-
scription includes synthesis of minus-strand DNA from the
pregenomic RNA template, degradation of the RNA template
as minus-strand synthesis proceeds, and synthesis of plus-
strand DNA from the minus-strand template. These steps are
predicted to be mediated by a virally encoded polymerase with
RNA- and DNA-dependent DNAp and RNase H activities
similar to those found in retroviruses.
RNases H hydrolyze only the RNA strand in RNA-DNA
hybrids (for a review, see reference 67). In retroviruses an
RNase H activity associated with the viral reverse transcriptase
(RT) is required for replication (for a review, see reference 7).
It degrades genomic RNA present in the RNA-DNA hybrid
generated during first-strand DNA synthesis so that the result-
ing single-stranded DNA molecule can serve as template for
second-strand synthesis. The RNase H activity also generates
the RNA primer for second-strand synthesis and is responsible
later for removing the tRNA and second-strand RNA primers
prior to completion of the double-stranded DNA molecule. In
hepadnaviruses, an RNase H activity is predicted to degrade
the pregenomic RNA molecule during minus-strand synthesis
and to generate an RNA oligomer that is used to prime plus-
strand synthesis. This oligoribonucleotide remains covalently
attached to the plus-strand of the genomic DNA molecule
until the virion infects a cell and formation of the covalently
closed, circular DNA molecule is initiated (32).
All hepadnaviruses contain similar versions of three genes
encoding core, envelope, and polymerase proteins. The mam-
malian viruses contain a fourth gene, X, encoding a protein of
unknown function. Expression of the structural core and en-
velope proteins is relatively well understood (for a review, see
reference 13). The nature of pol gene expression is not. Unlike
retroviral polymerases, the hepadnaviral polymerase is not ex-
pressed as a fusion protein (9, 49), although both core and
polymerase proteins are translated from the same mRNA (21,
38). The predicted amino acid sequences derived from hepad-
naviral pol genes contain motifs which are conserved among
the hepadnaviruses and are similar to sequences known to be
required for RT and RNase H activities in retroviruses (63). In
addition, the amino-terminal region contains residues which
are unique to and conserved among the hepadnaviral pol se-
quences (26). This region appears to be involved in priming
minus-strand synthesis (2, 70). The similarities between hep-
adnaviral and retroviral pol genes and evidence that replication
of the hepadnaviral DNA genome involves reverse transcrip-
tion have indicated the existence of a virally encoded, multi-
functional polymerase. In vitro transfection experiments which
examined the effects of mutations in the pol gene on produc-
tion of specific replicative intermediates suggested four do-
mains within the polymerase: an amino-terminal primer, a
spacer region, an RT, and a carboxy-terminal RNase H (8, 10,
31, 43).
Biochemical studies of the polymerase protein(s) have been
limited by unsuccessful attempts to purify useful quantities of
the protein(s) from virus particles. As a result, little is known
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about how the pol gene is expressed in vivo. Recently, several
groups have succeeded in expressing full-length polymerase
proteins in vitro which exhibit low levels of DNAp activity (20,
52, 59, 64). Two of these proteins have also been demonstrated
to have the ability to prime minus-strand synthesis via a ty-
rosine residue near their amino termini (66, 70). None of these
proteins has been demonstrated to have RNase H activity or to
complete minus-strand synthesis.
We have used activity gel assays to detect RNA- and DNA-
dependent DNAp activities in association with highly purified
DHBV core particles (37). Unlike the polymerase proteins
expressed in vitro, these activities were detected in prepara-
tions of core particles purified from infected animals and are
likely to represent polymerase proteins active in vivo. Our
results indicate that multiple polymerase proteins are ex-
pressed, perhaps functioning as a complex. We describe similar
studies here in which we have used an activity gel assay to
detect a single 35-kDa RNase H activity in association with
highly purified DHBV core particles and virus particles derived
from the sera of DHBV- and WHV-infected ducks and wood-
chucks, respectively. This is the first report describing detec-
tion of an RNase H activity associated with hepadnavirus par-
ticles. These data further support the suggestion that multiple
pol gene products are expressed in vivo and raise questions
about how they are synthesized, how they are packaged into
core particles, and how they carry out the various functions
attributed to them.
MATERIALS AND METHODS
Preparation of DHBV core particles. We have devised a protocol for the
purification of DHBV core particles to near homogeneity (37). Briefly, each
preparation of core particles was derived from 250 to 500 g of livers taken from
congenitally DHBV-infected Pekin ducks or Toulouse geese sacrificed 2 to 10
weeks posthatch (livers are usually taken from animals sacrificed 2 to 3 weeks
posthatch). Ducks were obtained as described previously (37) or hatched from
eggs congenitally infected with DHBV strain p2.3 (62). Geese were also hatched
from eggs congenitally infected with the DHBV p2.3 strain. Livers were homog-
enized by using a Dounce and loose-fitting pestle. Nuclei, large cellular material,
and polysomes were removed by differential centrifugation. Core particles were
concentrated by pelleting through a sucrose cushion and then fractionated from
large proteins and protein complexes by precipitation with polyethylene glycol.
Core particles were then isolated by sedimentation in one, two, or three sucrose
gradients followed by, in some cases, banding twice in a buoyant CsCl density
gradient. Fractions which contained core particles (density of 1.34 g/cm3) were
identified by the endogenous DNAp assay (37).
Preparation of virus particles from sera viremic for DHBV, Ross’s goose
hepatitis virus (RGHV), and WHV. Each preparation of DHBV was derived
from 75 to 100 ml of viremic serum taken from congenitally infected Pekin ducks
or Toulouse geese similar to those from which livers were taken for the purifi-
cation of DHBV core particles, as described above. All steps were carried out at
58C. Serum was cleared of cellular material and debris by low-speed centrifuga-
tion. Supernatants were pooled, and virus particles were pelleted in an SW27
rotor at 27,000 rpm for 28 h. Pellets were dissolved in virus buffer (VB) (0.15 M
NaCl, 1 mM EDTA, 20 mM Tris-HCl [pH 7.4]) and layered over a 3-ml cushion
of 20% sucrose–VB in an SW40 tube. Virus particles were pelleted through the
cushion in an SW40 rotor at 32,000 rpm for 17 h and redissolved in VB. The
sucrose cushion was diluted with VB and centrifuged in an SW40 rotor at 32,000
rpm for at least 8 h. The pelleted material, which contains some virions but is
enriched for surface antigen particles (36), was redissolved in VB and pooled
with the virion-enriched material which had been pelleted through the sucrose
cushion. We refer to this material as a crude preparation of virions. Crude virions
were further purified by mixing with CsCl in VB (0.235 g of CsCl per ml) and
centrifuging in an SW56 rotor at 48,000 rpm for 48 h. Fractions (100 ml) were
collected by bottom puncture and assayed for the presence of virions by using the
endogenous DNAp reaction and Southern blotting.
A crude preparation of RGHV was prepared as described for DHBV. RGHV
is an avian hepadnavirus whose genome sequence is distinct from that of DHBV
(53); it was isolated in our laboratory from a Ross’s goose. Serum (130 ml) was
taken from Pekin ducks which were congenitally infected with RGHV and
sacrificed 16 days posthatch. Material which had been pelleted through and from
the sucrose cushion was pooled and tested for RNase H activity.
WHV was prepared from the viremic serum of chronically infected wood-
chucks (provided by J. M. Cullen). WHV particles were pelleted through a
sucrose cushion as described for DHBV, redissolved in VB, mixed with CsCl in
VB (0.4 g of CsCl per ml), and centrifuged in an SW56 rotor at 48,000 rpm for
48 h. Fractions were collected by bottom puncture and assayed for the presence
of virions by using the endogenous DNAp reaction and Southern blotting. Frac-
tions which contained virions were diluted with VB and centrifuged in an SW56
rotor at 40,000 rpm for at least 8 h to concentrate virions and remove CsCl.
These fractions were then tested for RNase H activity.
Detection of virion DNA by Southern blotting. Fractions from CsCl density
gradients in which viremic sera from DHBV- or WHV-infected animals were
banded were assayed for the presence of viral DNA by Southern blotting and
hybridization with radiolabeled RNA probes. Samples (2 to 10 ml from 100-ml
fractions) were incubated at 378C for 1 h in the presence of 0.4% sodium dodecyl
sulfate (SDS)–0.4 mg of proteinase K per ml 0.02 M EDTA and then electro-
phoresed in a 1% agarose gel in E buffer (37). The gel was soaked in 0.1 M
NaOH–1.5 M NaCl for 30 min with shaking to denature DNA and hydrolyze
RNA and then neutralized by soaking in two changes of 0.1 M Tris-HCl and 1.5
M NaCl for 30 min each. DNA was transferred to a nylon membrane (Biotrans;
ICN Biomedicals) by upward capillary transfer from the gel (54). The membrane
was baked, prehybridized, and hybridized with a 32P-labeled DHBV plus-
stranded RNA probe for DHBV samples as described previously (37). For WHV
samples, a WHV plus-stranded RNA probe was prepared from a plasmid con-
struct similar to that described for DHBV probes, containing a full-length copy
of the WHV genome (11) as described previously (37). Washes were carried out
at 528C as described previously (37), and membranes were analyzed by autora-
diography.
RNase H activity gel assay. RNase H activity gel assays were carried out
essentially as described previously (55). Polyacrylamide gels (10% except where
noted otherwise, 0.75 mm thick) were prepared as described by Laemmli (28)
except for the addition of a M13 DNA–(32P)-labeled RNA hybrid to the gel mix
prior to polymerization. Samples were dissolved in, or diluted with, sample buffer
(final concentrations: 62.5 mM Tris-HCl [pH 6.8], 10% glycerol, 1% SDS, 5%
2-mercaptoethanol, 2 mM EDTA, 0.01% bromophenol blue) and electropho-
resed at 48C. All samples were heated for 4 min in a boiling water bath, except
where noted otherwise. Gels were then soaked in a series of buffers as described
previously (55), except that the 16- and 8-h incubations were done at 48C instead
of room temperature. After the final wash with trichloroacetic acid and NaPPi,
gels were stained with Coomassie blue for 40 min in 0.006% Coomassie blue
G250–7.5% methanol–5% acetic acid, destained for 20 min in 7.5% metha-
nol–5% acetic acid, dried under vacuum, and analyzed by autoradiography.
RNase H activity is observed as a clear area in the gel where the enzyme has
digested the 32P-labeled RNA in the DNA–(32P)-labeled RNA hybrid and the
products of the digestion have been washed out of the gel.
Ultrapure polyacrylamide was obtained from Bethesda Research Laboratories
(BRL), ultrapure SDS and dithiothreitol were obtained from Boehringer Mann-
heim Biochemicals, and glycerol was obtained from Fisher Scientific. All other
chemicals were purchased from Sigma. Exonuclease III was obtained from Pro-
mega or BRL. Protein molecular weight standards were from Promega. A prep-
aration of the p66 subunit of human immunodeficiency virus type 1 (HIV-1) RT,
which was purified from Escherichia coli expressing this polypeptide (29), was
provided by P. Furman, Burroughs Wellcome.
Preparation of DNA–32P-labeled RNA hybrid substrate.M13mp18 plus-strand
DNA was purified from the supernatant of infected E. coli JM101 (15). RNA
polymerase reactions were carried out in the presence of 4 mg of purified M13
DNA as described previously (19) with the addition of 10 mm of UTP. Total and
acid precipitable cpm in 1-ml aliquots were determined by scintillation counting.
Between 40 and 60% incorporation was generally observed. RNAp reactions
were terminated by adding EDTA to 20 mM, and the mixtures were then stored
at 48C without removing unincorporated [a-32P]UTP. A total of 100 ml of the
RNA polymerase reaction mixture was added per 15 ml of polyacrylamide gel,
and the unincorporated [a-32P]UTP was removed during electrophoresis.
RNA polymerase and ribonucleotides were obtained from Pharmacia.
[a-32P]UTP was from ICN Biomedicals or New England Nuclear, and all other
chemicals were from Sigma.
Immunoprecipitation of DHBV core particles. DHBV core particles were
immunoprecipitated with a rabbit antiserum generated against recombinant
DHBV core protein (23). Core particles, which had been isolated by sedimen-
tation in two sucrose gradients, were incubated on a rocker at 48C for at least 12
h with 2 ml of preimmune or immune serum or in the absence of serum in 500
ml of STE buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.1 mM EDTA, 1%
Triton X-100). Each immunoprecipitation reaction mixture contained 3% of the
total preparation of cores. A 50% slurry of IgGsorb (The Enzyme Center) in
STE buffer (50 ml) was then added to each immunoprecipitation reaction mix-
ture, and the mixtures were incubated on a 48C rocker for 1 to 1.5 h. The reaction
mixtures were pelleted in a microcentrifuge, and the pellets were washed three
times with 1 ml of STE buffer each time. The pellets were resuspended in 50 ml
of sample buffer and heated in a boiling water bath for 4 min. IgGsorb was
pelleted by microcentrifugation for 5 min at room temperature, and the super-
natants were tested in the RNase H activity gel assay.
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RESULTS
RNase H activity in crude preparations of DHBV core par-
ticles.DHBV core particles were prepared by sedimentation in
one sucrose gradient. Fractions containing significant endoge-
nous DNAp activity were pooled, and cores were pelleted by
centrifugation. Samples from this pool (equivalent to 2.6% of
the total preparation of cores) were tested in the RNase H
activity gel assay with and without boiling prior to electro-
phoresis. In this assay, RNase H activity is detected as a clear
band in the gel, representing a protein which has digested the
radiolabeled RNA of a DNA–32P-labeled RNA hybrid in situ.
A large, clear band indicative of RNase H activity was dis-
cerned in the autoradiograph at approximately 34 to 36 kDa
for both samples (Fig. 1A, lanes 1 and 4). Several fainter clear
bands were also observed between 50 to 91 kDa and between
20 to 30 kDa. Dark bands represent nucleic acid-binding pro-
teins which appear to retain labeled polymer during incuba-
tions in the various buffers (22). These proteins do not con-
centrate labeled polymer during electrophoresis since the dark
bands were not observed immediately after electrophoresis
(22). The RNase H activity at 34 to 36 kDa was located just
behind and in contact with a dark band identified as core
protein by its characteristic size and prominence in core prep-
arations (37, 42, 48). Its appearance as a dark band in this assay
is consistent with its property of binding nucleic acid moieties
(34, 39). These results indicate that the major RNase H activity
is efficiently renatured after the sample is boiled in SDS. They
also suggest that the RNase H released from core particles is
not associated noncovalently with nucleic acid or other pro-
teins that would retard its mobility in the gel.
A sample from the same DHBV core particle preparation
described for Fig. 1A taken just prior to sedimentation in
sucrose gradients was tested in the RNase H activity gel assay
by using an 8% polyacrylamide gel in an attempt to separate
the RNase H activity from core protein. A sample equivalent
to 0.3% of the total volume of cores at this stage of purification
was tested. A single clear band almost identical in size (35
kDa) to the one shown in Fig. 1A was discerned as a separate
moiety from the dark band of core protein (Fig. 1B, lane 5). As
an additional control, RNase H activity was not detected when
recombinant DHBV core protein (produced in E. coli and
provided by A. Jilbert) was tested in the RNase H activity gel
assay (data not shown). These data indicate that the core-
associated RNase H activity is not an integral part of, or de-
pendent upon, contact with core protein.
RNase H activity in preparations of DHBV core particles
purified to near homogeneity. To more rigorously define the
association of the 35-kDa RNase H with DHBV core particles,
their further purification was carried out by two different meth-
ods: (i) banding in buoyant CsCl density gradients (37) and (ii)
immunoprecipitation of DHBV cores by an antiserum specific
for DHBV core protein.
(i) RNase H activity is associated with liver-derived DHBV
core particles purified to near homogeneity by banding in
CsCl. DHBV core particles were purified to near homogeneity
by buoyant density centrifugation in two CsCl gradients, and
fractions from the final CsCl gradient were analyzed for the
presence of core protein, endogenous DNAp, and RNase H
activities. Endogenous DNAp activity was recovered in frac-
tions 27 to 34, with peak activity in fraction 29 (Fig. 2A). Core
protein was the predominant protein in all fractions tested but
was most abundant in fractions 29 to 31 (Fig. 2B). It was
identified in the Coomassie-stained activity gel by its charac-
FIG. 1. RNase H activity gel assays with crude preparations of DHBV core
particles. (A) DHBV core particles before (lane 1) and after (lane 4) boiling.
Faint RNase H activities between 50 and 91 kDa are bracketed. Lane 2 contained
;1 mg of purified HIV RT (p66); weaker RNase H activities were also detected
in this preparation at 54 kDa (an apparent degradation product) and ;130 kDa
(an apparent homodimer of p66). Lane 3 contained 1,000 U of Moloney murine
leukemia virus RT (p80). Lanes 1 to 3 are from the same gel, and lane 4 is from
a gel run in parallel. (B) DHBV core particles (lane 5) were tested in the RNase
H activity gel assay using an 8% polyacrylamide gel to separate the RNase H
activity from core protein. Lane 6 contained ; 1 mg of purified HIV RT (p66)
and exonuclease III (p28, 8 U from BRL) which also exhibits RNase H activity.
Lanes 5 and 6 were from the same gel. Arrows point to the dark, hybrid-binding
bands composed of core protein. Molecular size markers (in kilodaltons [kd]) are
represented by lines beside the gels and were used to align lanes taken from
different gels. PAG, polyacrylamide gel.
FIG. 2. Endogenous DNAp and RNase H activities associated with CsCl
gradient fractions containing DHBV core particles purified to near homogeneity.
Cores were banded twice in CsCl gradients, pelleted from the final gradient
fractions, and resuspended in 100 ml of core buffer (37). Fractions are numbered
from the bottom of the gradient to the top. (A) Fractions were assayed using the
endogenous DNAp reaction. Incorporation of [a-32P]dGTP was detected by
scintillation counting. Fractions (20 ml of samples) were also tested in the RNase
H activity gel assay in which the activity gel was stained with Coomassie blue (B)
and then analyzed by autoradiography (C). Regions of the gel above and below
the 35-kDa RNase H activity have been omitted from the figure since no activity
was detected in these areas. Lane E contained 250 U of exonuclease III from
Promega. Molecular size markers (in kilodaltons [kd]) are represented by lines
beside the gels and were used to align lanes taken from different gels.
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teristic size (32 to 34 kDa) (42, 48). RNase H activity was
detected as a single band with an apparent molecular mass of
35 kDa in fractions 28 to 33, with maximal activity in fractions
30 and 31 (Fig. 2C). The fainter clear bands at 50 to 91 kDa
and 20 to 30 kDa which were present in the crude preparation
of core particles (Fig. 1A) were not detected in association
with core particles purified through two CsCl density gradients.
These bands may represent RNase H activities which are not
derived from DHBV and are lost upon banding in CsCl, or
they may be DHBV polymerase proteins which have RNase H
activity but are sensitive to exposure to CsCl.
The peak of RNase H activity in the CsCl gradient is over-
lapping, but not precisely concordant with maximal endoge-
nous DNAp activity. The fractionation of RNase H activity is
more precisely concordant with the distribution of core protein
and is maximal in fractions which are found on the slightly less
dense side of the peak endogenous DNAp activity.
These data identify a single RNase H associated with highly
purified DHBV core particles. RNase H activity was not de-
tected in the absence of markers for core particles (endoge-
nous DNAp activity and core protein) or in identically pre-
pared material from the livers of DHBV-negative ducks (data
not shown).
(ii) RNase H activity is associated with liver-derived DHBV
core particles which have been immunoprecipitated. DHBV
core particles were prepared by sedimentation in two sucrose
gradients and immunoprecipitated with a rabbit antiserum
generated against recombinant DHBV core protein. The im-
munoprecipitate was tested for RNase H activity in the gel
assay to determine whether core particles isolated by immu-
noprecipitation were associated with the same RNase H activ-
ity observed with core particles isolated by banding in CsCl.
Figure 3A shows the Coomassie-stained activity gel in which
core protein can be seen in lane 2, the material immunopre-
cipitated with anti-core antiserum, but not in lanes 1 (preim-
mune serum) or 3 (no serum). The autoradiograph of this gel
shows a single RNase H activity at 34 kDa, just above the dark
band of core protein in the anti-core antiserum reaction mix-
ture (Fig. 3B, lane 2) but not in the presence of preimmune
serum (Fig. 3B, lane 1) or in the absence of serum (Fig. 3B,
lane 3). This activity appears to be identical to the major
RNase H active band detected in association with crude and
highly purified core particles (Fig. 1 and 2). In all three cases
a single RNase H activity was discerned at ca. 34 kDa, just
above a dark band of core protein. The fainter RNase H
activities at 51 to 94 kDa and the dark, hybrid-binding protein
bands other than core protein which were seen with the crude
preparation of cores were not seen with CsCl-banded or im-
munoprecipitated cores. These data indicate that the 34- or
35-kDa RNase H activity is closely associated with core parti-
cles and is not adversely affected by exposure to CsCl.
RNase H activity in preparations of hepadnavirus particles
from viremic sera. Since hepadnaviral core particles are pre-
cursors to infectious virions, it seemed likely that DHBV in
viremic serum would also display the RNase H activity found
associated with the liver-derived DHBV core particles. Thus, a
crude preparation of virions pelleted from sera viremic for
DHBV and a CsCl gradient fraction containing buoyant
DHBV were tested in the RNase H activity gel assay. Both
samples contained a single RNase H activity nearly identical in
size (ca. 35 kDa) to that detected in association with DHBV
core particles (Fig. 4, lanes 3 and 4). Additionally, a crude
preparation of virions from sera viremic for RGHV and also a
CsCl gradient fraction containing WHV were similarly as-
sayed. Both the RGHV (Fig. 4, lane 5) and WHV (Fig. 4, lane
6) preparations displayed a single RNase H activity nearly
identical in size to the RNase H activity associated with the
serum- and liver-derived DHBV particles. These results indi-
cate that both mammalian and avian hepadnaviruses are asso-
ciated with RNase H activities which are very similar, if not
identical, in size.
The RNase H associated with DHBV is more active with
magnesium than manganese ions. Virions from sera viremic
for hepatitis B virus have been shown to exhibit greater endo-
genous DNAp activity when magnesium rather than manga-
nese ions are added to the reaction mixture (25). We have
observed with DHBV core particles that synthesis of both
minus- and plus-strand DNA, as measured in the endogenous
DNAp reaction, is stronger in the presence of magnesium ions
than with manganese ions (data not shown). DHBV core par-
ticles isolated by sedimentation in three sucrose gradients and
a crude preparation of virions from serum viremic for DHBV
were tested in the RNase H activity gel assay in the presence of
8 mM MgCl2 or 8 mM MnCl2. Sample sizes were both equiv-
alent to 2% of each of the total core and virion preparations,
respectively. The 35-kDa RNase H activity, which was detected
in association with both DHBV cores and crude virions in the
presence of MgCl2, was not detected in the preparation of core
particles when MnCl2 was substituted for MgCl2 (Fig. 5). The
RNase H activity associated with serum-derived virus particles
was significantly reduced in the presence of MnCl2 but not
completely inactive. These results support the idea that the
RNase H activities associated with both DHBV cores and
crude virions are the same and, like the endogenous DNAp
activity, are more active with magnesium rather than manga-
nese ions under these conditions.
FIG. 3. RNase H activity gel assay on DHBV core particles which were
immunoprecipitated with an antiserum directed against DHBV core protein.
The activity gel was stained with Coomassie blue (A) and then analyzed by
autoradiography (B). Lanes: 1, immunoprecipitation reaction mixture to which
preimmune serum was added; 2, reaction mixture with anti-core antiserum; 3,
reaction mixture without serum. Regions of the gel above and below the 34-kDa
RNase H activity have been omitted from the figure since no activity was de-
tected in these areas. Lane E contained exonuclease III (250 U; Promega). Molec-
ular size markers (in kilodaltons [kd]) are represented by lines beside the gels.
FIG. 4. RNase H activity gel assays with preparations of DHBV, RGHV, and
WHV from viremic sera. Lanes: 2, 2% of a preparation of DHBV core particles
isolated through two sucrose gradients; 3, DHBV from viremic serum which was
banded in a CsCl gradient and pelleted from one fraction in which significant
amounts of viral DNA and endogenous DNAp activity were detected; 4 and 5,
each contained 1% of crude preparations of DHBV and RGHV, respectively;
both were pelleted from viremic sera; 6, 10% of a CsCl fraction in which
significant amounts of WHV DNA and endogenous DNAp activity were de-
tected; 1, exonuclease III (250 U; Promega). None of the serum-derived samples
was heated prior to electrophoresis. Lanes 1 to 3, 4 and 5, and 6 were taken from
three separate gels, respectively. Molecular size markers (in kilodaltons [kd]) rep-
resented by lines beside the gels, were used to align lanes taken from separate gels.
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DISCUSSION
We have previously described detection of RNA- and DNA-
dependent DNAp activities associated with highly purified
DHBV core particles, using activity gel assays (37). The re-
quirement for an RNase H activity in the hepadnaviral repli-
cation scheme and the likelihood of its existence based on
genetic studies and amino acid sequence analyses prompted us
to use the same approach to look for RNase H activity in
preparations of virus particles.
An RNase H activity at 34 to 36 kDa was detected in a crude
preparation of DHBV core particles. This activity was detected
both with and without boiling, indicating that it can be rena-
tured in the activity gel assay and that it is not associated
noncovalently with nucleic acid or other proteins. A nearly
identical RNase H activity at 35 kDa was detected in CsCl
gradient fractions containing DHBV core particles purified to
near homogeneity. This RNase H activity was not detected in
the absence of endogenous DNAp activity or core protein, nor
was it detected in similar preparations from uninfected ducks.
It was also detected in association with core particles which
had been immunoprecipitated with antiserum generated
against recombinant DHBV core protein. The CsCl gradient
fractions in which the RNase H activity was detected were
nearly identical to those in which RNA- and DNA-dependent
DNAp activities were detected in a similar preparation of core
particles described previously (37). These activities were con-
cordant with peak amounts of core protein and endogenous
DNAp activity, suggesting an association of all three activities
with core particles. We have also detected a single RNase H
activity at 35 kDa in preparations of DHBV, RGHV, and
WHV from viremic sera. Although these virus particles were
not purified to near homogeneity, the detection of an RNase H
activity nearly identical to that identified with highly purified
DHBV core particles suggests that these RNase H activities
are the same. Although it is possible that the 35-kDa RNase H
is encoded by the host genome, detection of nearly identical
RNase H activities associated with cytoplasmic core particles
isolated from avian liver tissue and extracellular virus particles
prepared from the sera of both avian and mammalian hosts
suggests that this RNase H activity is derived from the viral pol
gene which is conserved among all members of the Hepadna-
viridae family. Since it was detected in preparations of both
immature core particles and crude virions, the RNase H activ-
ity appears to be retained after its predicted function in de-
grading the pregenomic RNA template is apparently com-
pleted. Perhaps in virions this RNase H activity is involved in
removal of the RNA oligomer covalently attached to the 59 end
of the plus-strand prior to completion of plus-strand synthesis
and formation of the covalently closed, circular DNA mole-
cule. If so, the RNase H activity, like the polymerase activity
appears to be restrained during secretion of mature virions.
The RNase H activity that we have detected is markedly
smaller than the predicted full-length product of the pol open
reading frame (ORF) (p85 for DHBV and p90 for WHV) and
might arise by any of several mechanisms. In retroviruses and
caulimoviruses, RT is expressed as a precursor protein with
little or no activity until proteolytic processing by the viral
protease (14, 57). The 35-kDa RNase H might arise by pro-
teolytic cleavage from a larger molecule either prior to or after
its association with the hepadnaviral nucleocapsid. Although
expression of a full-length pol ORF product which is then
proteolytically processed has not been ruled out, there is no
evidence for a viral protease in hepadnaviruses. Initiation of
translation at internal in-frame AUG codons allows for the
synthesis of more than one protein from a single ORF. In
general, this is not a common stratagem for protein synthesis in
eucaryotes, but at least half of all hepadnaviral proteins are
generated in this way (for a review, see reference 13). The pol
ORF contains numerous in-frame ATG codons, some of which
are conserved among all members of the Hepadnaviridae fam-
ily. Translation beginning at a conserved methionine codon at
480 in the DHBV pol gene and at 551 in the WHV pol gene
would produce a 34- to 36-kDa protein containing the con-
served amino acid motifs essential for activity in characterized
RNase H proteins. This protein would be predicted to lack RT
activity since it does not contain all of the residues known to be
required for RT activity. The multiple core-associated RNA-
and DNA-dependent DNAp activities that we detected using
activity gel assays are larger than (109 kDa), the same size as
(85 kDa), and smaller than (80, 75, and 63 kDa) the predicted
full-length DHBV pol gene product (37). These data suggest
that the 35-kDa RNase H activity does not also have DNAp
activity. However, like the endogenous DNAp activity ob-
served with DHBV core particles and virions, the RNase H
activities detected in preparations of DHBV core particles and
crude virions are stronger in the presence of magnesium rather
than manganese ions.
It is unclear why we did not detect the activities of RNase H
proteins of the same sizes as the DNAp proteins found in the
DNAp activity gel assays, since at least the larger proteins
would be expected to contain the RNase H domain. If larger
pol ORF products have RNase H activity in vivo, they may not
be detected by using this assay because of difficulties in rena-
turation (45) or a requirement for formation of a protein
complex, such as a dimer. Alternatively, RNase H activity may
be restricted to the 35-kDa protein and is inactive as part of a
larger polymerase protein. It is not apparent whether this 35-
kDa RNase H activity acts alone, in concert with viral poly-
merase activities, or in addition to a putative RNase H activity
associated with larger pol ORF products. Three of the best-
characterized RTs (avian myeloblastosis virus, Moloney mu-
rine leukemia virus, and HIV-1) possess an RNase H activity
which is physically linked to the polymerase as part of the same
polypeptide (14, 30, 58). If the 35-kDa RNase H activity that
we have detected is involved in virus replication, it would be
the first example of an RNase H activity which must coordinate
its activity with the RT as a separate entity.
In light of the similarities among reverse-transcribing ele-
ments, it is tempting to look at recurring themes among the
better-characterized retroviral RTs to make sense of what little
is known about the hepadnaviral RT. The three best-charac-
terized retroviral RTs (avian myeloblastosis virus, Moloney
murine leukemia virus, and HIV-1) share the ability to form
and function as dimeric moieties (14, 60, 61). For HIV-1,
FIG. 5. RNase H activities associated with DHBV cores and crude virions in
the presence of magnesium or manganese ions. Cores which had been isolated by
sedimentation in sucrose gradients (lanes marked C) and crude virions (lanes
marked V) were tested in RNase H activity gel assays in the presence of MgCl2
(A) or MnCl2 (B). None of these samples was heated prior to electrophoresis.
Lanes C and V in panel A were from the same gel, while lanes C and V in panel
B were from a separate gel run in parallel. Molecular size markers (in kilodaltons
[kd]) are represented by lines beside the gels and were used in align the lanes
from separate gels.
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reverse transcription is carried out by a p66-p51 heterodimer
which is formed initially as a p66 homodimer. One copy of p66
within the homodimer appears to be vulnerable to cleavage by
the viral protease, while a conformational difference protects
the other copy from proteolysis (27). The resulting p51 mole-
cule does not appear to have RT or RNase H activities within
the heterodimer, but it does play a key role in positioning the
tRNA primer for first-strand synthesis. It may also help to
stabilize interactions between the enzyme and its substrate,
thereby increasing processivity. There have been reports that
p15 is present within virion particles and exhibits RNase H
activity in activity gel assays (16, 50). It has been suggested that
this RNase H activity may act randomly because of its small
size and ‘‘unlinking’’ from the polymerase domain (47). It is
possible that this RNase H activity may have an accessory role
in replication as a nonprocessive RNase H. The association of
less-than-full-length DNAp and RNase H activities with hep-
adnavirus particles suggests that the replication process is car-
ried out by a protein complex, perhaps a dimer as seen with the
retroviral RTs. As with the HIV-1 p15 RNase H, the role of the
p35 RNase H activity that we have detected has yet to be
defined.
If the 35-kDa RNase H activity that we have detected is a
product of the pol ORF and involved in replication, a mecha-
nism must exist for packaging it along with the DNAp active
protein(s). Little is known about how the pol gene product(s)
is packaged into core particles. In vitro studies with full-length
Pol proteins expressed from plasmid constructs or by in vitro
translation indicate that polymerase is required as a structural
protein for packaging of (preferentially) the pregenomic RNA
from which it is translated (1, 18). It appears to interact with an
encapsidation signal, epsilon, at the 59 end of the pregenomic
RNA, but the nature of this interaction is unknown (24, 41,
65). Mutations made in all three functional domains have been
shown to interfere with packaging of pregenomic RNA and
polymerase (1, 46). However, there have been no reports of
studies in which Pol proteins truncated from the amino termi-
nus and corresponding to the minimal predicted RT or RNase
H domains have been tested for the ability to be packaged. Wu
et al. have reported that a DHBV pol mutant generated from
a frameshift mutation in the spacer region apparently pack-
aged the terminal protein domain separately from the RT and
RNase H domains and was able to carry out reverse transcrip-
tion of the pregenomic RNA, although at a reduced rate com-
pared with that of the wild-type virus (68). Their data indicate
that packaging of subgenic pol proteins is possible, perhaps via
individual packaging signals or formation of a protein complex.
The presence of a second copy of the encapsidation signal at
the 39 end of the pregenomic RNA suggests that a second Pol
protein or complex might bind there and perhaps form a
dimeric complex with the 59 Pol protein. Since the 39 epsilon is
not sufficient by itself for packaging, it has been suggested that
differences in the sequences adjacent to the 39 and 59 epsilons
affect their abilities to direct packaging (3, 40). Perhaps the 39
epsilon represents a second, but distinct, binding site for a Pol
protein which is different from that which binds to the 59 copy.
This might provide the means by which subgenic Pol proteins
are packaged and interact to form an enzyme complex. This
possibility is supported by the findings of Wang and Seeger
(65). Their RNA template from which a 90-kDa DHBV poly-
merase protein is expressed in vitro lacks the 59 epsilon; yet, in
some cases, initiation of minus-strand DNA took place at the
39 epsilon, indicating an interaction between polymerase pro-
tein and the 39 epsilon.
It is also unclear to what extent core protein interacts with
the polymerase protein(s) and the pregenomic RNA during
and after formation of core particles. Several studies have
suggested that core protein may play a role in positioning
and/or condensing replicative intermediates during replication
(17, 35, 69). We have observed a strong interaction between
core protein and the 35-kDa RNase H activity. DHBV core
particles, treated with 5% SDS in an attempt to dissociate core
and polymerase proteins, were subjected to immunoprecipita-
tion with an antiserum generated against recombinant DHBV
core protein. The immunoprecipitated material was tested in
the RNase H activity gel assay. We observed the characteristic
dark band of core protein and the 35-kDa RNase H activity
(data not shown). This observation suggests a strong interac-
tion between viral core and Pol proteins, in addition to the
interactions observed between Pol protein and viral DNA (2,
6) and core protein and viral DNA (5, 12, 24, 39). A better
understanding of these associations may be a key factor in
overcoming the technical difficulties encountered by us and
others in studying the viral Pol protein(s) in vivo and in ex-
pressing active Pol proteins.
Activity gel assays have allowed us to detect all three of the
enzymatic activities predicted to be encoded by the pol ORF
and required for hepadnaviral replication. We have argued
that they most likely represent pol gene products, but studies
demonstrating a direct relationship have been unsuccessful so
far. The identification of Pol proteins from virus particles by
using immunoprecipitation or Western blot (immunoblot)
analyses has largely been unsuccessful. There have been two
reports in which Pol proteins were identified from virus parti-
cles. Bavand et al. used antisera generated against peptides
derived from the predicted Pol protein to immunoprecipitate a
70-kDa protein from HBV particles produced in vitro which
exhibited RT activity in an activity gel assay (4). Mack et al.
identified a 65-kDa protein in hepatitis B virus virions from an
infected patient by Western blotting with an antiserum gener-
ated against a tribrid fusion protein which included 143 amino
acids from the predicted Pol protein (33). These results and
our own strongly suggest that enzymatically active subgenic Pol
proteins are expressed and packaged into virus particles. It is
unclear why such Pol proteins have not been detected in any of
the in vitro systems used recently to express the full-length pol
ORF. Possibly, the conditions under which subgenic Pol pro-
teins are generated in vivo are not accurately reproduced in
these systems. The DNAp and priming activities exhibited by
the full-length Pol proteins further support the idea that the
pol ORF encodes these functions required during virus repli-
cation. However, these results do not preclude the possibility
that these functions may be carried out more efficiently in virus
particles by a complex including less-than-full-length Pol pro-
teins.
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